Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
Two Stocks Set to Capitalize on the Surging Weight Loss Drug Trend
October 19, 2023
From TalkMarkets
Healthcare Portfolio Focus Stocks
October 16, 2023
From TalkMarkets
Psychedelic-Compound-Based Drug Stocks Continue To Fall
October 15, 2023
From TalkMarkets
Week In Review: Two China Biopharmas Announce Billion Dollar Deals
October 14, 2023
From TalkMarkets
BIIB Stock Price Analysis: To Bet Or To Fold The Cards
October 14, 2023
Tickers
BIIB
From TalkMarkets
Large Cap Biopharmaceuticals-Core Holdings For Your Healthcare Portfolio Until M&A Action Picks Up
October 09, 2023
From TalkMarkets
The Canadian Cannabis Report - Monday, Oct. 9
October 09, 2023
From TalkMarkets
Week In Review: QYuns Plans Hong Kong IPO For Autoimmune/Allergic Disease Portfolio
October 07, 2023
From TalkMarkets
Major Psychedelic Drug Stocks Continued To Decline This Week
October 06, 2023
From TalkMarkets
Chart Of The Day: Tango Therapeutics - What Happens When The FDA Gives A Thumbs UP!
October 06, 2023
Tickers
TNGX
From TalkMarkets
Biotech Sector: On The Verge Of Triumph Or Turmoil?
October 06, 2023
From TalkMarkets
Consolidation In Viking Therapeutics Provides An Opportunity
October 01, 2023
Tickers
VKTX
From TalkMarkets
September Summary: Largest Psychedelic Drug Stocks Dropped 14%
October 01, 2023
From TalkMarkets
Week In Review: Adlai Nortye Stages $97.5 Million US IPO On Nasdaq
September 30, 2023
From TalkMarkets
Some Economics Of Pharmacy Benefit Managers
September 28, 2023
From TalkMarkets
Roivant Stock Price Outlook: Strong Pipeline Is A Catalyst
September 27, 2023
From TalkMarkets
Psychedelic Drug Stocks Dragged Down By 83% Collapse In SEEL Stock Price
September 24, 2023
From TalkMarkets
Week In Review: Everest Acquires Novel Autoimmune Therapy In $132 Million Agreement
September 23, 2023
From TalkMarkets
How The Same Treatments May Work For Multiple Neurodegenerative Diseases
September 21, 2023
From TalkMarkets
From TalkMarkets
4 Of The 6 Largest Psychedelic Compound-Based R & D Stocks Had A Good Week
September 17, 2023
From TalkMarkets
Week In Review: Hasten Signs $325 Million Deal For China Rights To PCSK9 Cholesterol Therapy
September 16, 2023
From TalkMarkets
Healthcare Playbook Revisited - Growth Plus Value
September 13, 2023
From TalkMarkets
CVS And Cigna Charge $6,000 For $55 Generics, How Do We Fix This?
September 12, 2023
From TalkMarkets
Roivant Sciences: Is Vivek Ramaswamy’s Biotech Stock A Buy?
September 10, 2023
Tickers
ROIV
From TalkMarkets
6 Largest Psychedelic Compound-Based R & D Stocks In Decline
September 10, 2023
From TalkMarkets
Healthcare Portfolio: A Mixed Market Looking for Value
September 05, 2023
From TalkMarkets
From TalkMarkets